Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-034873
Filing Date
2012-05-09
Accepted
2012-05-09 09:54:19
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12-6486_110q.htm 10-Q 951253
2 EX-31.1 a12-6486_1ex31d1.htm EX-31.1 19197
3 EX-31.2 a12-6486_1ex31d2.htm EX-31.2 19218
4 EX-32.1 a12-6486_1ex32d1.htm EX-32.1 7437
  Complete submission text file 0001104659-12-034873.txt   7939953

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mnta-20120331.xml EX-101.INS 1056104
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnta-20120331.xsd EX-101.SCH 80835
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnta-20120331_cal.xml EX-101.CAL 38741
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT mnta-20120331_lab.xml EX-101.LAB 1258209
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnta-20120331_pre.xml EX-101.PRE 536467
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnta-20120331_def.xml EX-101.DEF 357257
Mailing Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Filer) CIK: 0001235010 (see all company filings)

EIN.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50797 | Film No.: 12824096
SIC: 2836 Biological Products, (No Diagnostic Substances)